Figure 2:. Antifungal use during AML induction across U.S. children's hospitals, adjusted for institutional demographic variables and frequency of severe illness days
Figure 2:

Antifungal use during AML induction across U.S. children's hospitals, adjusted for institutional demographic variables and frequency of severe illness days

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal